Study of Magnesium Sulfate Iontophoresis for Treating Lateral Epicondylitis Tennis Elbow in Adults Ages 20 to 50

What this Trial Is About

Researchers are evaluating the effect of magnesium sulfate on pain intensity, muscle power, hand grip, and functional ability in patients with lateral epicondylitis, also known as tennis elbow. This condition involves tendinopathy of the forearm extensor muscles and commonly affects people aged 40 years and older. The study aims to understand whether magnesium sulfate administered via iontophoresis has a significant impact on these symptoms compared to conventional therapy alone. The study involves two treatment groups. One group will receive iontophoresis therapy where magnesium sulfate is applied to the active positive electrode twice a week for four weeks, combined with conventional therapy including splinting, stretching, and strengthening exercises. The other group will receive only the conventional therapy twice a week for six weeks. This design allows comparison between the magnesium sulfate iontophoresis plus conventional therapy and conventional therapy alone. Participants will be involved in treatments and assessments over a six-week period. Researchers will measure outcomes such as pain intensity, muscle power, hand grip strength, and functional ability of the affected arm. Additional assessments include monitoring elbow range of motion. The study uses a randomized, double-blind design to ensure unbiased results, with safety and effect evaluations conducted throughout the study period.

Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients